HCA Healthcare, Inc. (FRA:2BH)
Germany
· Delayed Price · Currency is EUR 421.00
+6.00 (1.45%)
At close: Dec 4, 2025
HCA Healthcare Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 95,469 | 73,435 | 65,546 | 63,479 | 70,263 | 45,493 | Upgrade
|
| Market Cap Growth | 19.09% | 12.04% | 3.26% | -9.66% | 54.45% | 1.83% | Upgrade
|
| Enterprise Value | 137,103 | 116,778 | 104,414 | 101,788 | 101,426 | 68,582 | Upgrade
|
| Last Close Price | 414.50 | 289.26 | 239.58 | 216.58 | 218.64 | 127.82 | Upgrade
|
| PE Ratio | 17.66 | 13.20 | 13.82 | 12.02 | 11.49 | 14.82 | Upgrade
|
| PS Ratio | 1.51 | 1.08 | 1.12 | 1.13 | 1.36 | 1.08 | Upgrade
|
| PB Ratio | -51.88 | 136.99 | 68.35 | -929.32 | 53.67 | 19.24 | Upgrade
|
| P/FCF Ratio | 13.84 | 13.48 | 15.46 | 16.44 | 14.85 | 8.70 | Upgrade
|
| P/OCF Ratio | 8.73 | 7.23 | 7.68 | 7.96 | 8.92 | 6.03 | Upgrade
|
| EV/Sales Ratio | 2.14 | 1.71 | 1.78 | 1.81 | 1.96 | 1.63 | Upgrade
|
| EV/EBITDA Ratio | 9.81 | 8.72 | 9.09 | 9.05 | 9.21 | 8.40 | Upgrade
|
| EV/EBIT Ratio | 13.64 | 11.46 | 11.99 | 12.02 | 11.92 | 11.55 | Upgrade
|
| EV/FCF Ratio | 19.87 | 21.44 | 24.62 | 26.36 | 21.43 | 13.11 | Upgrade
|
| Debt / Equity Ratio | -21.47 | 81.51 | 39.49 | -550.68 | 24.67 | 11.45 | Upgrade
|
| Debt / EBITDA Ratio | 2.86 | 3.03 | 3.06 | 3.09 | 2.72 | 3.04 | Upgrade
|
| Debt / FCF Ratio | 5.73 | 8.02 | 8.93 | 9.74 | 6.83 | 5.18 | Upgrade
|
| Asset Turnover | 1.25 | 1.22 | 1.20 | 1.17 | 1.20 | 1.11 | Upgrade
|
| Inventory Turnover | 24.84 | 22.31 | 19.27 | 18.28 | 18.08 | 16.65 | Upgrade
|
| Quick Ratio | 0.64 | 0.85 | 0.87 | 1.00 | 1.01 | 1.03 | Upgrade
|
| Current Ratio | 0.85 | 1.08 | 1.18 | 1.38 | 1.41 | 1.42 | Upgrade
|
| Return on Equity (ROE) | - | 824.40% | 1234.24% | 965.25% | 352.48% | 377.05% | Upgrade
|
| Return on Assets (ROA) | 12.20% | 11.39% | 11.07% | 10.97% | 12.31% | 9.81% | Upgrade
|
| Return on Capital (ROIC) | 16.18% | 14.86% | 14.49% | 14.45% | 16.30% | 12.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 27.80% | 23.80% | 22.10% | 21.30% | 23.50% | 18.70% | Upgrade
|
| Earnings Yield | 5.66% | 7.58% | 7.23% | 8.32% | 8.71% | 6.75% | Upgrade
|
| FCF Yield | 7.23% | 7.42% | 6.47% | 6.08% | 6.73% | 11.49% | Upgrade
|
| Dividend Yield | 0.60% | 0.88% | 0.91% | 0.97% | 0.77% | 0.27% | Upgrade
|
| Payout Ratio | 10.75% | 11.98% | 12.61% | 11.57% | 8.97% | 4.08% | Upgrade
|
| Buyback Yield / Dilution | 7.57% | 5.28% | 6.19% | 10.37% | 4.32% | 1.33% | Upgrade
|
| Total Shareholder Return | 8.17% | 6.17% | 7.10% | 11.34% | 5.10% | 1.60% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.